Correlation Between Nasdaq and COSCIENS Biopharma

Can any of the company-specific risk be diversified away by investing in both Nasdaq and COSCIENS Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nasdaq and COSCIENS Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nasdaq Inc and COSCIENS Biopharma, you can compare the effects of market volatilities on Nasdaq and COSCIENS Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nasdaq with a short position of COSCIENS Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nasdaq and COSCIENS Biopharma.

Diversification Opportunities for Nasdaq and COSCIENS Biopharma

-0.88

Correlation Coefficient

Nasdaq  COSCIENS Biopharma

Pay attention - limited upside

The 3 months correlation between Nasdaq and COSCIENS is -0.88. Overlapping area represents the amount of risk that can be diversified away by holding Nasdaq Inc and COSCIENS Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on COSCIENS Biopharma and Nasdaq is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nasdaq Inc are associated (or correlated) with COSCIENS Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of COSCIENS Biopharma has no effect on the direction of Nasdaq i.e., Nasdaq and COSCIENS Biopharma go up and down completely randomly.

Pair Corralation between Nasdaq and COSCIENS Biopharma

Given the investment horizon of 90 days Nasdaq Inc is expected to generate 0.25 times more return on investment than COSCIENS Biopharma. However, Nasdaq Inc is 4.01 times less risky than COSCIENS Biopharma. It trades about 0.07 of its potential returns per unit of risk. COSCIENS Biopharma is currently generating about -0.13 per unit of risk. If you would invest  7,954  in Nasdaq Inc on September 18, 2024 and sell it today you would earn a total of  92.00  from holding Nasdaq Inc or generate 1.16% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Nasdaq Inc  vs.  COSCIENS Biopharma

Nasdaq Inc

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Nasdaq Inc are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Nasdaq may actually be approaching a critical reversion point that can send shares even higher in January 2025.

COSCIENS Biopharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days COSCIENS Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Nasdaq and COSCIENS Biopharma

The main advantage of trading using opposite Nasdaq and COSCIENS Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nasdaq position performs unexpectedly, COSCIENS Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in COSCIENS Biopharma will offset losses from the drop in COSCIENS Biopharma's long position.

The idea behind Nasdaq Inc and COSCIENS Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.